Open AccessFactors affecting the duration of phase 1 of dexamethasone-immunosuppressant pulse therapy for pemphigus group of disorders: A 10-year retrospective study in a tertiary care center
Author(s) -
Vidya Mundakkat,
Rajiv Sridharan
Publication year - 2018
Publication title -
indian dermatology online journal
Language(s) - English
Resource type - Journals
eISSN - 2249-5673
pISSN - 2229-5178
DOI - 10.4103/idoj.idoj_74_18
Subject(s) - tertiary care , medicine , dexamethasone , retrospective cohort study , pemphigus , center (category theory) , duration (music) , dermatology , art , literature , chemistry , crystallography
Dexamethasone-immunosuppressant pulse therapy introduced by Pasricha et al . in 1981 as a treatment for long-term remission in pemphigus group of disorders has gained wide acceptance in many places, especially India. Since the overall duration of treatment is determined by the duration of phase 1 of the regime, identification of factors that influence phase 1 may be particularly helpful in addressing patient's concerns and apprehensions before initiation of treatment so that compliance can be improved.